South Texas Accelerated Therapeutics

START Center for Cancer Research is an oncology-focused clinical research organization and site network specializing in early-phase cancer trials. Originally known as South Texas Accelerated Research Therapeutics, START operates a large community-based network that conducts Phase 1 and other early clinical studies for biopharma sponsors developing novel anticancer therapies. The company provides clinical trial execution, translational research, preclinical and protocol support, and access to specialized oncology investigators and patients. Its capabilities span solid tumors and, more recently, expanded hematologic malignancy trial support. START is headquartered in San Antonio, Texas and has grown into a global network with sites and partnerships across the United States and internationally.